Cargando…

Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review

The aim of our study was to evaluate the effectiveness of lurasidone augmentation of clozapine in treatment-resistant schizophrenia (SZ) in a retrospective chart review. From the medical records of 916 SZ patients, we identified 16 individuals treated with a combination of clozapine and lurasidone....

Descripción completa

Detalles Bibliográficos
Autores principales:	Siwek, Marcin, Chrobak, Adrian Andrzej, Gorostowicz, Aleksandra, Król, Patrycja, Dudek, Dominika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046327/ https://www.ncbi.nlm.nih.gov/pubmed/36979255 http://dx.doi.org/10.3390/brainsci13030445

Ejemplares similares

Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2021)

Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report
por: Siwek, Marcin, et al.
Publicado: (2021)

TED—Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode—Preliminary Report
por: Siwek, Marcin, et al.
Publicado: (2023)

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023)

Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study
por: Arienti, V., et al.
Publicado: (2023)

Unprescribed and unnoticed: Retrospective chart review of adverse events of interactions between antidepressants and over-the-counter drugs
por: Woroń, Jarosław, et al.
Publicado: (2022)

Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
por: Siwek, Marcin, et al.
Publicado: (2022)

Polish adaptation of the Dimensional Anhedonia Rating Scale (DARS) - validation in the clinical sample
por: Gorostowicz, Aleksandra, et al.
Publicado: (2023)

Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs
por: Siwek, Marcin, et al.
Publicado: (2023)

When practice does not make a perfect - paradoxical learning curve in schizophrenia and bipolar disorder revealed by different serial reaction time task variants
por: Chrobak, Adrian Andrzej, et al.
Publicado: (2023)

Graph Analysis of Verbal Fluency Tests in Schizophrenia and Bipolar Disorder
por: Chrobak, Adrian Andrzej, et al.
Publicado: (2022)

Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders
por: Siwek, Marcin, et al.
Publicado: (2023)

Machine Learning-Based Identification of Suicidal Risk in Patients With Schizophrenia Using Multi-Level Resting-State fMRI Features
por: Bohaterewicz, Bartosz, et al.
Publicado: (2021)

Clinical potential of lurasidone in the management of schizophrenia
por: Samalin, Ludovic, et al.
Publicado: (2011)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2012)

Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2017)

Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review
por: Seddigh, Ruohollah, et al.
Publicado: (2015)

Clozapine monitoring at a specialised psychiatric hospital: A retrospective chart review
por: Daniels, Michelle V., et al.
Publicado: (2023)

Psychopharmacology and Biological Studies of Psychosis
por: Siwek, Marcin, et al.
Publicado: (2023)

The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey, Philip D
Publicado: (2015)

Identification of clinical phenotypes in schizophrenia: the role of lurasidone
por: Riva, Marco Andrea, et al.
Publicado: (2021)

Lurasidone for the treatment of schizophrenia in adult and paediatric populations
por: Guilera, Teresa, et al.
Publicado: (2023)

Pimozide Augmentation of Clozapine in Hebephrenic Schizophrenia: A Case Report
por: Mendhekar, D.N., et al.
Publicado: (2003)

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
por: Eryılmaz, Gül, et al.
Publicado: (2013)

Altered Functional Connectivity Differences in Salience Network as a Neuromarker of Suicide Risk in Euthymic Bipolar Disorder Patients
por: Sobczak, Anna Maria, et al.
Publicado: (2020)

Schizophrenia relapse, patient considerations, and potential role of lurasidone
por: Citrome, Leslie
Publicado: (2016)

Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
por: Javed, Afzal, et al.
Publicado: (2019)

Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia
por: Meltzer, Herbert Y., et al.
Publicado: (2020)

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
por: Miura, Itaru, et al.
Publicado: (2023)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Clozapine augmentation strategies
por: Roerig, James L.
Publicado: (2019)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
por: Peitl, Vjekoslav, et al.
Publicado: (2023)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
por: Johannsen, Claas-Frederik, et al.
Publicado: (2022)

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2015)

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
por: Ogasa, Masaaki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c3tc62h69g6gqeurvo8s6u4khe